Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring-Reference-Cited by-同舟云学术

Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring

Published:2013-11-08 Issue:1 Volume:10 Page:
ISSN:1542-6416
Container-title:Clinical Proteomics
language:en
Short-container-title:Clin Proteom

Author:

Cerciello Ferdinando,Choi Meena,Nicastri Annalisa,Bausch-Fluck Damaris,Ziegler Annemarie,Vitek Olga,Felley-Bosco Emanuela,Stahel Rolf,Aebersold Ruedi,Wollscheid Bernd

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Clinical Biochemistry,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/1559-0275-10-16.pdf

Reference76 articles.

1. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, DeCamp MM, Swanson SJ, Bueno R, Lukanich JM: Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999, 117: 54-63. discussion 63–55,

2. Weder W, Kestenholz P, Taverna C, Bodis S, Lardinois D, Jerman M, Stahel RA: Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J Clin Oncol. 2004, 22: 3451-3457.

3. Flores RM, Krug LM, Rosenzweig KE, Venkatraman E, Vincent A, Heelan R, Akhurst T, Rusch VW: Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol. 2006, 1: 289-295.

4. Weder W, Stahel RA, Bernhard J, Bodis S, Vogt P, Ballabeni P, Lardinois D, Betticher D, Schmid R, Stupp R: Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol. 2007, 18: 1196-1202.

5. Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, Rosenzweig KE, Flores R, Friedberg JS, Pisters K, Monberg M: Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol. 2009, 27: 3007-3013.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Site-Specific N-Linked Glycosylation Analysis of Human Carcinoembryonic Antigen by Sheathless Capillary Electrophoresis–Tandem Mass Spectrometry;Journal of Proteome Research;2021-02-09

2. Circulating biomarkers in malignant pleural mesothelioma;Exploration of Targeted Anti-tumor Therapy;2020-12

3. Mesothelioma Biomarkers;Thoracic Surgery Clinics;2020-11

4. Verification of a Blood-Based Targeted Proteomics Signature for Malignant Pleural Mesothelioma;Cancer Epidemiology Biomarkers & Prevention;2020-07-30

5. Mesothelioma Biomarkers: A Review Highlighting Contributions from the Early Detection Research Network;Cancer Epidemiology Biomarkers & Prevention;2020-07-22